Regulation of kappa opioid receptor mRNA in the rat brain by 'binge' pattern cocaine administration and correlation with preprodynorphin mRNA

Molecular Brain Research

Volumn 38, Issue 1, 1996, Pages 71-76

  Spangler, Rudolph ^a   Ho, Ann ^a   Zhou, Yan ^a   Maggos, Christopher E ^a   Yuferov, Vadim ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Brain; Cocaine; Kappa opioid receptor; Preprodynorphin; Preproenkephalin; Rat

Indexed keywords

BRAIN RECEPTOR; COCAINE; KAPPA OPIATE RECEPTOR; MESSENGER RNA; PRODYNORPHIN; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG ABUSE; GENE EXPRESSION REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0030014579     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00319-N     Document Type: Article

References (45)

1. Batsche, K., Granoff, M.I. and Wang, R.Y., 5-HT3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of AlO dopamine neurons in the rat, Brain Res., 592 (1992) 273-277.
2. Branch, A.D., Unterwald, E.M., Lee, S.E. and Kreek, M.J., Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay, Mol. Brain Res., 14 (1992) 231-238.
3. Cameron, D.L. and Williams, J.T., Dopamine D1 receptors facilitate transmitter release, Nature, 366 (1993) 344-347.
4. Chen, Y., Mestek, A., Liu, J. and Yu, L., Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors, Biochem. J., 295 (1993) 625-628.
5. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
6. Civelli, O., Douglass, J., Goldstein, A. and Herbert, E., Sequence and expression of the rat prodynorphin gene, Proc. Natl. Acad. Sci. USA, 82 (1985) 4291-4295.
7. Daunais, J.B. and McGinty, F., Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs, Mol. Brain Res., 29 (1995) 201-210.
8. Daunais, J.B., Roberts, D.C. and McGinty, J.F., Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum, NeuroReport, 4 (1993) 543-546.
9. Delfs, J.M., Yu, L., Ellison, G.D., Reisine, T. and Chesselet, M.F., Regulation of mu-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration, J. Neurochem., 63 (1994) 777-780.
10. Delfs, J.M., Yu, L., Reisine, T. and Chesselet, M., The distribution and regulation of mu opioid receptor mRNA in rat basal ganglia, Regul. Peptides, 54 (1994) 79-80.
11. Devi, L., Douglass, J. and Herbert, E., A solution hybridization assay for the quantitation of prodynorphin mRNA, Brain Res., 388 (1987) 173-176.
12. Erickson, J.M., Rushford, C.L., Dorney, D.J., Wilson, G.N. and Schmickel, R.D., Structure and variation of human ribosomal DNA: molecular analysis of cloned fragments, Gene, 16 (1981) 1-9.
13. Filloux, F., Dawson, T.M. and Wamsley, J.K., Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase, Brain Res. Bull., 20 (1988) 447-459.
14. 3H]sulpiride, Eur. J. Pharmacol., 138 (1987) 61-68.
15. Hannon, G.J., Maroney, P.A., Branch, A., Benenfield, B.J., Robertson, H.D. and Nilsen, T.W., Accurate processing of human pre-rRNA in vitro, Mol. Cell Biol., 9 (1989) 4422-4431.
16. Heikkila, R.E., Orlansky, H. and Cohen, G., Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices, Biochem. Pharmacol., 24 (1975) 847-852.
17. Hellmann, W., Suzuki, F., Ohkubo, H., Nakanishi, S., Ludwig, G. and Ganten, D., Angiotensinogen gene expression in extrahepatic rat tissues: application of a solution hybridization assay, Naunyn-Schmiedeberg's Arch. Pharmacol., 338 (1988) 327-331.
18. Hillis, D. and Dixon, T., Ribosomal DNA: Molecular evolution and phylogenetic inference, Q. Rev. Biol., 66 (1991) 411-453.
19. Hurd, Y.L., Brown, E.E., Finlay, J.M., Fibiger, H.C. and Gerfen, C.R., Cocaine self-administration differentially alters mRNA expression of striatal peptides, Mol. Brain Res., 13 (1992) 165-170.
20. Hurd, Y.L. and Herkenham, M., Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides, Mol. Brain Res., 16 (1992) 97-104.
21. Kalivas, P.W. and Duffy, P., Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya, J. Neurosci., 13 (1993) 276-284.
22. 2 receptors in rat substantia nigra neurones, J. Physiol., 401 (1988) 437-453.
23. Maisonneuve, I.M. and Kreek, M.J., Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study, J. Pharmacol. Exp. Ther., 268 (1994) 916-921.
24. Mansour, A., Khachaturian, H., Lewis, M.E., Akil, H. and Watson, S.J., Anatomy of CNS opioid receptors, Trends Neurosci., 11 (1988) 308-314.
25. Manzanares, J., Lookingland, K.J. and Moore, K.E., Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain, J. Pharmacol. Exp. Ther., 256 (1991) 500-505.
26. Meng, F., Xie, G.X., Thompson, R.C., Mansour, A., Goldstein, A., Watson, S.J. and Akil, H., Cloning and pharmacological characterization of a rat kappa opioid receptor, Proc. Natl. Acad. Sci. USA, 90 (1993) 9954-9958.
27. Mereu, G., Casu, M. and Gessa, G.L., (-)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats, Brain Res., 264 (1983) 105-110.
28. Minami, M., Hosoi, Y., Toya, T., Katao, Y., Maekawa, K., Katsumata, S., Yabuuchi, K., Onogi, T. and Satoh, M., In situ hybridization study of K-opioid receptor mRNA in the rat brain, Neurosci. Lett., 162 (1993) 161-164.
29. Mulder, A.H., Wardeh, G., Hogenboom, F. and Frankhuyzen, A.L., κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release, Nature, 308 (1984) 278-280.
30. Pickel, V.M., Chan, J. and Sesack, S.R., Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra, Brain Res., 602 (1993) 275-289.
31. Pucak, M.L. and Grace, A.A., Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors, J. Pharmacol. Exp. Ther., 271 (1994) 1181-1192.
32. Reid, M., Herrera-Marschitz, M., Hokfelt, T., Terenius, L. and Ungerstedt, U., Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P, Eur. J. Pharmacol., 147 (1988) 411-420.
33. Reith, M.E., Sershen, H. and Lajtha, A., Saturable (3H)cocaine binding in central nervous system of mouse, Life Sci., 27 (1980) 1055-1062.
34. Roth, R.H., CNS dopamine autoreceptors: Distribution, pharmacology and function, Ann. N.Y. Acad. Sci., 430 (1984) 27-53.
35. Sivam, S.P., Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism, J. Pharmacol. Exp. Ther., 250 (1989) 818-824.
36. Smiley, P.L., Johnson, M., Bush, L., Gibb, J.W. and Hanson, G.R., Effects of cocaine on extrapyramidal and limbic dynorphin systems, J. Pharmacol. Exp. Ther., 253 (1990) 938-943.
37. Spangler, R., Unterwald, E.M. and Kreek, M.J., 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen, Mol. Brain Res., 19 (1993) 323-327.
38. Spangler, R., Zhou, Y., Unterwald, E.M., Yuferov, V., Ho, A. and Kreek, M.J., Kappa opioid receptor mRNA levels in the rat brain: effects of dopamine antagonists and cocaine. In E.J. Simon (Ed.), Regulatory Peptides, Vol. 54, Elsevier, Amsterdam, 1994, p. 283.
39. Steiner, H. and Gerfen, C.R., Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum, J. Neurosci., 13 (1993) 5066-5081.
40. Unterwald, E.M., Knapp, C. and Zukin, R.S., Neuroanatomical localization of kappa 1 and kappa 2 opioid receptors in rat and guinea pig brain, Brain Res., 562 (1991) 57-65.
41. Vincent, S.R., Hokfelt, T., Christensson, I. and Terenius, L., Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway, Eur. J. Pharmacol., 85 (1982) 251-252.
42. Werling, L.L., Frattali, A., Portoghese, P.S., Takemori, A.E. and Cox, B.M., Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs, J. Pharmacol. Exp. Ther., 246 (1988) 282-286.
43. Yoshikawa, K., Williams, C. and Sabol, S.L., Rat brain preproenkephalin mRNA: cDNA cloning, primary structure, and distribution in the central nervous system, J. Biol. Chem., 259 (1984) 14301-14308.
44. You, Z.B., Herrera-Marschitz, M., Nylander, I., Goiny, M., O'Connor, W.T., Ungerstedt, U. and Terenius, L., The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis-II. Effects of dopamine D1 and D2 receptor agonists, Neuroscience, 63 (1994) 427-434.
45. Zhu, Y.S., Branch, A.D., Robertson, H.D., Huang, T.H., Franklin, S.O. and Inturrisi, C.E., Time course of enkephalin mRNA and peptides in cultured rat adrenal medulla, Mol. Brain Res., 12 (1992) 173-180.